Latest Articles
Merck-Kelun ADC boosts survival in phase 3 endometrial cancer, stokes TROP2 race - CHOSUNBIZ - Chosunbiz
Merck-Kelun ADC boosts survival in phase 3 endometrial cancer, stokes TROP2 race - CHOSUNBIZ Chosunbiz
Published: May 19, 2026, 6:54 a.m.
Professor Avery’s AI research reveals 20% have undiagnosed endometriosis - Daily Telegraph Sydney
Professor Avery’s AI research reveals 20% have undiagnosed endometriosis Daily Telegraph Sydney
Published: May 19, 2026, 2:34 a.m.
Merck's Sac-TMT Shows Promise in Advanced Endometrial Cancer Tri - GuruFocus
Merck's Sac-TMT Shows Promise in Advanced Endometrial Cancer Tri GuruFocus
Published: May 18, 2026, 11:38 p.m.
Merck (MRK) Achieves Milestone in Endometrial Cancer Treatment T - GuruFocus
Merck (MRK) Achieves Milestone in Endometrial Cancer Treatment T GuruFocus
Published: May 18, 2026, 10:39 p.m.
Merck’s TROP2 ADC opens global women’s cancer push with endometrial win - BioCentury
Merck’s TROP2 ADC opens global women’s cancer push with endometrial win BioCentury
Published: May 18, 2026, 10:04 p.m.
Professor Avery’s AI research reveals 20% have undiagnosed endometriosis - The Weekly Times
Professor Avery’s AI research reveals 20% have undiagnosed endometriosis The Weekly Times
Published: May 18, 2026, 9:17 p.m.
Yana Aznavour, MD, PhD, on a non-invasive menstrual blood diagnostic platform for endometriosis - Contemporary OB/GYN
Yana Aznavour, MD, PhD, on a non-invasive menstrual blood diagnostic platform for endometriosis Contemporary OB/GYN
Published: May 18, 2026, 8:17 p.m.
Sac-TMT Significantly Improves PFS/OS in Pretreated Endometrial Cancer - CancerNetwork
Sac-TMT Significantly Improves PFS/OS in Pretreated Endometrial Cancer CancerNetwork
Published: May 18, 2026, 7:33 p.m.
Professor Avery’s AI research reveals 20% have undiagnosed endometriosis - Adelaide Now
Professor Avery’s AI research reveals 20% have undiagnosed endometriosis Adelaide Now
Published: May 18, 2026, 5:52 p.m.
MSD’s sac-TMT meets primary endpoints in Phase III endometrial cancer trial - Yahoo
MSD’s sac-TMT meets primary endpoints in Phase III endometrial cancer trial Yahoo
Published: May 18, 2026, 4:44 p.m.
Link copied to clipboard!